Cuts built into the 2010 Medicare Physician Fee Schedule will imperil community-based imaging facilities, ultimately restricting availability of advanced imaging techniques to large hospitals, according to American College of Radiology.
Cuts built into the 2010 Medicare Physician Fee Schedule will imperil community-based imaging facilities, ultimately restricting availability of advanced imaging techniques to large hospitals, according to American College of Radiology. If this happens, patients will face longer commutes and wait times to receive care, causing life threatening delays in diagnosis and treatment of cancer and other serious illnesses, according to the ACR. At issue is a change in the imaging equipment utilization rate assumption from the current 50% rate to 90%, effectively cutting reimbursement by some 44%. CMS will also implement new practice expense data collected through the Physician Practice Information Survey (PPIS) further decreasing reimbursement to CT and MRI scans.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.